Retatrutide vs. Tirzepatide: GLP-1 Research Comparison
Retatrutide and Tirzepatide are both incretin-receptor-agonist peptides studied in metabolic and obesity-related preclinical research, but they are not interchangeable research tools: Tirzepatide is a dual-receptor agonist, while Retatrutide adds a third receptor target entirely. Understanding what separates them matters for choosing the right compound for a given research question. Tirzepatide: Dual GIP/GLP-1 Receptor Agonism Tirzepatide […]









